Issues in performing a network meta-analysis

@article{Senn2013IssuesIP,
  title={Issues in performing a network meta-analysis},
  author={Stephen J Senn and Françoise Gavini and David Magrez and Andr{\'e} Scheen},
  journal={Statistical Methods in Medical Research},
  year={2013},
  volume={22},
  pages={169 - 189}
}
The example of the analysis of a collection of trials in diabetes consisting of a sparsely connected network of 10 treatments is used to make some points about approaches to analysis. In particular various graphical and tabular presentations, both of the network and of the results are provided and the connection to the literature of incomplete blocks is made. It is clear from this example that is inappropriate to treat the main effect of trial as random and the implications of this for analysis… Expand

Figures, Tables, and Topics from this paper

GetReal in network meta-analysis: a review of the methodology.
TLDR
This article presents a review of the relevant literature on NMA methodology aiming to pinpoint the developments that have appeared in the field. Expand
Random main effects of treatment: A case study with a network meta-analysis.
TLDR
It is illustrated how a hierarchical approach to modeling a random main effect of treatment can be used to produce shrunk (toward the overall mean) estimates of effects for individual treatments. Expand
The Impact of Performing a Network Meta-Analysis with Imperfect Evidence
TLDR
This thesis investigates methods for dealing with imperfect evidence by considering two techniques for adjusting for confounding variables due to differing patient populations in a connected network and proposing a method for including single-arm evidence in a disconnected network through aggregate level matching. Expand
Visualizing the flow of evidence in network meta-analysis and characterizing mixed treatment comparisons.
TLDR
A display of the flow of evidence and new measures that characterize the structure of a mixed treatment comparison are proposed and seen to render transparent the process of data pooling in mixed treatment comparisons in network meta-analysis. Expand
Statistical Models and Methods for Network Meta-Analysis.
TLDR
The methods and models for conducting a network meta-analysis based on frequentist statistical principles are reviewed, and the procedures using a published multi-treatment plant pathology data set are demonstrated. Expand
Network meta-analysis and random walks
TLDR
This work uses the graph representation of NMA to construct the transition matrix for a random walk on the network of evidence and derives analytically the matrix of proportion contributions from this analogy. Expand
Visualizing inconsistency in network meta-analysis by independent path decomposition
TLDR
The approximation of the network estimate for a single comparison by the evidence of a subnet and the visualisation of the decomposition into independent paths provide the applicability of a graphical validation instrument that is known from classical meta-analysis. Expand
A generalized pairwise modelling framework for network meta-analysis
TLDR
A generalized pairwise modelling (GPM) framework for network meta-analysis, so named as it is based on the repeated application of adjusted indirect comparisons, also known as the Bucher method is introduced. Expand
Detecting outlying trials in network meta-analysis.
TLDR
Several Bayesian outlier detection measures are proposed, which are then applied to a diabetes data set and compared to conventional pairwise meta-analysis settings. Expand
A graphical tool for locating inconsistency in network meta-analyses
TLDR
The net heat plot is provided, to render transparent which direct comparisons drive each network estimate and to display hot spots of inconsistency, which permits singling out which of the suspicious direct comparisons are sufficient to explain the presence of inconsistency. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 42 REFERENCES
Graphical exploration of network meta-analysis data: the use of multidimensional scaling
TLDR
Multidimensional scaling provides a useful tool for investigators to visualize the network of randomized comparisons and to assess incoherence of the network, without making any distributional assumptions. Expand
Network meta-analysis for indirect treatment comparisons.
I present methods for assessing the relative effectiveness of two treatments when they have not been compared directly in a randomized trial but have each been compared to other treatments. TheseExpand
Evaluation of networks of randomized trials
TLDR
The concept of inconsistency and methods that have been proposed to evaluate it as well as the methodological gaps that remain are discussed and the implications of inconsistency, network geometry and asymmetry in informing the planning of future trials are discussed. Expand
The Many Modes of Meta
TLDR
The options open to the meta-analyst in drug development are examined and comparisons to approaches used in analyzing multicenter trials are made in an attempt to provide some unifying insights, in particular as regards the handling of models with interactions. Expand
Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.
TLDR
This report from the International Society for Pharmacoeconomics and Outcomes Research Indirect Treatment Comparisons Good Research Practices Task Force provides guidance on technical aspects of conducting network meta-analyses (the authors' use of this term includes most methods that involve meta-analysis in the context of a network of evidence). Expand
Combination of direct and indirect evidence in mixed treatment comparisons.
  • G. Lu, A. Ades
  • Mathematics, Medicine
  • Statistics in medicine
  • 2004
TLDR
A range of Bayesian hierarchical models using the Markov chain Monte Carlo software WinBUGS are presented that allow for variation in true treatment effects across trials, and models where the between-trials variance is homogeneous across treatment comparisons are considered. Expand
Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated
TLDR
This paper distinguishes between the concepts of clinical and statistical heterogeneity and exemplifies the importance of investigating heterogeneity by using published meta-analyses of epidemiological studies of serum cholesterol concentration and clinical trials of its reduction. Expand
Random-effects model for meta-analysis of clinical trials: an update.
TLDR
It is shown that the leading methods for estimating the inter-study variance are special cases of a general method-of-moments estimate of the inter"-study variance" and suggested two new two-step methods. Expand
Meta-analysis of mixed treatment comparisons at multiple follow-up times.
TLDR
This work extends mixed treatment comparisons to a more complex situation where trials report results at one or more, different yet fixed, follow-up times and develops a series of Bayesian hierarchical models based on piece-wise exponential hazards that have a very wide potential application. Expand
Lessons from TGN1412 and TARGET: implications for observational studies and meta-analysis.
  • S. Senn
  • Medicine
  • Pharmaceutical statistics
  • 2008
Two very different studies are examined: the first, a very large trial in osteoarthritis (the so-called TARGET study) and the second a very small 'first-in-man' study of the monoclonal antibodyExpand
...
1
2
3
4
5
...